| Cat.No.: | CKLF2-227M |
| Product Overview: | Recombinant MCV CKLF2 (Accession # AAB72041) Leu25-Leu104 was produced in E. coli-derived. |
| Source: | E. coli |
| Species: | MCV |
| Predicted N Terminal: | Leu25 |
| Form: | Lyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
| Bio-activity: | Measured by its ability to block I-309-induced chemotaxis of BaF3 mouse pro-B cells transfected with human CCR8.The ED50 for this effect is typically 15 - 75 ng/mL in the presence of 20 ng/mL rhI-309. |
| Molecular Mass: | Recombinant MCV CKLF2 has a calculated MW of 9.1 kDa. |
| Purity: | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage: | Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
| Reconstitution: | Reconstitute at 100 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.
Download Datasheet
See All CKLF2 Products
Download Datasheet